You are on Trendlyne India.
Click here
to go to United States website or make
India
as your default
Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Events Calendar
What's New
Explore
FAQs
Widgets
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Login / Sign up
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Eris Lifesciences Ltd.
Swot
Eris Lifesciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Eris Lifesciences Ltd. has 16 Strengths, 10 Weaknesses, 5 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(16)
Weakness
(10)
Opportunity
(5)
Threats
(1)
Others
(4)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years - Nifty500
Expensive Rockets (DVM)
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Book Value per share Improving for last 2 years
RSI indicating price strength
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Promoter decreasing their shareholding
PE higher than Industry PE
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Performance of Stocks with Low Trendlyne Durability Score versus Benchmarks
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
High promoter stock pledges
Brokers upgraded recommendation or target price in the past three months
Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months
MFs decreased their shareholding last quarter
Rising Delivery Percentage Compared to Prev Day
Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)
